Democritus University of Thrace (DUTH)
Συγκριτική μελέτη της συμβολής της μισοπροστολής και μιφεπριστονής στο μη επεμβατικό τερματισμό κυήσεων 1ου τριμήνου
Abstract
dc:descriptionPurpose: The best method for medical abortion depends a lot on the week of pregnancy and the final result varies depending on the experience of the medical staff. The purpose of this study was to investigate the efficacy of medical abortion with misoprostol and a combination of mifepristone and misoprostol. The rate of induced abortions has variable reported frequency, lower in countries with well-organized family planning services and higher in poor societies, in which social and economic pressures lead people to achieve fertility goals without family planning services. Epidemiological studies carried out have confirmed that the human reproductive system is perfectly regulated to produce a minimal optimal period between the pregnancies. The management of unwanted pregnancies and subsequent contraception is of great importance especially for women interested in childbirth, the teenagers who need to be informed about available options of contraception to protect their fertility. The main challenge nowadays remains to ensure efficacy of the methods widely used for abortion and to make them available to the majority of women in the world. The induced abortion rate beyond the 1st trimester is less than 15% of all reported procedures in the world, and in particular in Europe it ranges between 2% and 10%. Unfortunately, it is estimated that approximately twenty-two million unsafe abortions are performed each year and 98% are performed in developing countries. Unsafe abortion is defined as a termination of pregnancy in which women undergo abortion without completing the medical standards and recommendations that is not in accordance of the safety of this procedure procedure. Improvement of mother’s health and in line with international development and safety goals should be in mind to prevent maternal mortality and morbidity. Health impact of the unsafe abortions depends on the abortion method used, pregnancy week and finally the experience and training of the obstetrician performing the abortion. Although the use of contraception has led to a decrease in the number of unintended pregnancies, however, approximately 33 million contraceptive users report accidental pregnancy. About 85 million (41%) of the 208 million women estimated to be pregnant worldwide each year are considered unwanted pregnancies. The recommended medical method for abortion is the use of mifepristone alone or in combination with misoprostol. The efficacy and safety of termination of pregnancy with the pharmaceutical method and with no hospital stay will be investigated.Patients and methods: During the period April 2007 to December 2017, 200 women who were pregnant up to 49 days after LMP (last menstrual period) underwent pregnancy termination using A1 Mifegyn 600 mg oral or A2 800 mg tablets Misoprostol (Cytotec) intravaginally and in another 200 pregnant women whose gestation was between 49-63 days were given B1 600 mg Mifepristone orally administered tablets followed 48 hours later 800 mcg Misoprostol (Cytotec) or B2 Only Misoprostol (Cytotec) . All participants subscribe written consent for surgical treatment in case that it would be necessary. An ultrasound scan was performed to confirm an intrauterine pregnancy prior to medical abortion. The indications for abortion were as follows: missed miscarriage, intrauterine death, spontaneous recurrent miscarriages, termination of the pregnancy.Results: According to our study, no woman had to undergo surgery to complete the abortion. Common side effects such as nausea, vomiting, pain and moderate vaginal bleeding were observed without need of hospitalization. Bleeding occurred earlier in group A1 compared to group A2. In addition, miscarriage began approximately 3.5 hours earlier in Group A1 compared to Group A2. Similarly, the time between administration and abortion was 50% shorter in group A1 compared to group A2. The duration of bleeding in group B1 of group B2 was similar in both groups. Analgesia was not necessary for any participant, but it was used more than 7 times more frequent in group B2 than in group B1. Admission by pregnant women to the study was high. Close medical follow-up and frequent control of ultrasound and biochemical parameters were determined as a problem and the same was the case with prolonged abdominal pain. Conclusion: The combination of mifepristone and misoprostol and sole administration of mifepristone are safe and effective for medical termination of pregnancy in the first trimester.
Degree
thesis:*- Grantor dc:publisher
- Democritus University of Thrace (DUTH)
- Year dc:date
- 2019
Author and committee
dc:creator, dc:contributor.*- Authors dc:creator
-
- Stanulov, Georgi
- Στανούλοβ, Γκεόργκι
Subjects
dc:subject × 14- Έκτρωση 1ου τριμήνου
- Φαρμακευτική έκτρωση
- Μιφεπριστόνη
- Μισοπροστόλη
- Συνδυασμός μισοπροστόλης / μιφεπριστόνης
- Induced abortion 1st trimester
- Medical abortion
- Mifepristone
- Misoprostol
- Combination of mifepristone and misoprostol
- Ιατρική και Επιστήμες Υγείας
- Κλινική Ιατρική
- Medical and Health Sciences
- Clinical Medicine
Rights
- Language dc:language
- gre
Identifiers
dc:identifier.*- Identifier
- 10.12681/eadd/46618